Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;22(5):443-8.
doi: 10.1097/CCO.0b013e32833d7dbe.

Controversies in the treatment of Burkitt lymphoma in AIDS

Ariela Noy  1
Affiliations
Review

Controversies in the treatment of Burkitt lymphoma in AIDS

Ariela Noy. Curr Opin Oncol. 2010 Sep.

Abstract

Purpose of review: The success of combined antiretroviral therapy (cART) has transformed HIV infection into a survivable chronic disease in developed countries. Increasingly then, the risks of HIV associated cancers become paramount. Burkitt lymphoma is one of the cancer subtypes highly disproportionately affecting HIV infected patients.

Recent findings: Recent conference proceedings appear to corroborate early reports that intensive therapy of HIV-Burkitt lymphoma is feasible and effective. An optimal approach is not defined due to the small numbers of patients in current trials and the absence of comparison studies. Moreover, as breakthroughs in the pathogenesis of lymphoma in general and Burkitt lymphoma in particular suggest that HIV infection plays a significant role, the opportunity for targeted therapy based on differences in biology are wholly untapped.

Summary: Advances are being made in HIV-Burkitt lymphoma, but future studies need to incorporate our expanding understanding of biology to improve efficacy and reduce toxicity, preferably by integrating a biologic approach to this curable disease.

PubMed Disclaimer

References

    1. Carbone A, et al. AIDS-related Burkitt’s lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol. 1995;103(5):561–7. - PubMed
    1. Levine AM. AIDS-associated malignant lymphoma. Med Clin North Am. 1992;76(1):253–68. - PubMed
    1. Beral V, et al. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991;337(8745):805–9. - PubMed

    1. Magrath I. Lessons from clinical trials in African Burkitt lymphoma. Curr Opin Oncol. 2009;21(5):462–8.* An outstanding review of the history of BL in Africa from its discovery to its current state.

    1. Adde M, et al. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol. 1998;25(2 Suppl 4):33–9. discussion 45-8. - PubMed

Publication types

MeSH terms

Substances